Over her 20-year career to date, Oxana has worked across multiply therapeutic modalities in both pharma and biotech settings, with significant experience in cell therapy and biologics for Oncology indications. Oxana was a founding scientist and head of discovery for immunotherapy  company Adaptate Biotherapeutics, the spin out of cell therapy company Gamma Delta Therapeutics.

Oxana holds a PhD from Moscow State University.